FI973063L - Guaniinijohdannainen - Google Patents

Guaniinijohdannainen Download PDF

Info

Publication number: FI973063L
Authority: FI; Finland
Prior art keywords: guanine derivative; guanine; derivative
Prior art date: 1995-01-20

Application number

FI973063A

Other languages

English (en)

Finnish (fi)

Swedish (sv)

Other versions

FI973063A0 (fi

FI973063A7 (fi

Inventor

Barry Howard Carter

Jane Muse Partin

Peter Gregory Varlashkin

Richard Augustus Winnike

William Bayne Grubb

Gregory Alan Conway

Philip George Lake

David Michael Skinner

David James Whatrup

Original Assignee

Wellcome Found

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-01-20

Filing date

1996-01-19

Publication date

1997-09-18

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10768347&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI973063(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1996-01-19 Application filed by Wellcome Found filed Critical Wellcome Found

1997-07-18 Publication of FI973063A0 publication Critical patent/FI973063A0/fi

1997-09-18 Publication of FI973063L publication Critical patent/FI973063L/fi

1997-09-18 Publication of FI973063A7 publication Critical patent/FI973063A7/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Virology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Saccharide Compounds (AREA)

FI973063A 1995-01-20 1996-01-19 Guaniinijohdannainen FI973063A7 (fi)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9501178.9A GB9501178D0 (en)	1995-01-20	1995-01-20	Guanine derivative
PCT/GB1996/000117 WO1996022291A1 (en)	1995-01-20	1996-01-19	Guanine derivative

Publications (3)

Publication Number	Publication Date
FI973063A0 FI973063A0 (fi)	1997-07-18
FI973063L true FI973063L (fi)	1997-09-18
FI973063A7 FI973063A7 (fi)	1997-09-18

Family

ID=10768347

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI973063A FI973063A7 (fi)	1995-01-20	1996-01-19	Guaniinijohdannainen

Country Status (40)

Country	Link
US (1)	US6107302A (xx)
EP (1)	EP0804436B1 (xx)
JP (1)	JP3176633B2 (xx)
KR (1)	KR100376074B1 (xx)
CN (1)	CN1049893C (xx)
AP (1)	AP662A (xx)
AR (1)	AR002270A1 (xx)
AT (1)	ATE302777T1 (xx)
AU (1)	AU702794B2 (xx)
BG (1)	BG63393B1 (xx)
BR (1)	BR9606768A (xx)
CA (1)	CA2210799C (xx)
CY (1)	CY2531B1 (xx)
CZ (1)	CZ297065B6 (xx)
DE (1)	DE69635106T2 (xx)
DK (1)	DK0804436T3 (xx)
EA (1)	EA000364B1 (xx)
EE (1)	EE03528B1 (xx)
ES (1)	ES2248806T3 (xx)
FI (1)	FI973063A7 (xx)
GB (1)	GB9501178D0 (xx)
GE (1)	GEP20001940B (xx)
HR (1)	HRP960024B1 (xx)
HU (1)	HU222993B1 (xx)
IL (1)	IL116831A (xx)
IN (1)	IN182468B (xx)
IS (1)	IS2268B (xx)
NO (1)	NO315558B1 (xx)
NZ (1)	NZ298851A (xx)
OA (1)	OA10499A (xx)
PL (1)	PL182175B1 (xx)
RO (1)	RO118693B1 (xx)
RS (1)	RS49518B (xx)
SI (1)	SI0804436T1 (xx)
SK (1)	SK285329B6 (xx)
TR (1)	TR199700656T1 (xx)
UA (1)	UA46001C2 (xx)
UY (1)	UY25779A1 (xx)
WO (1)	WO1996022291A1 (xx)
ZA (1)	ZA96449B (xx)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9501178D0 (en) *	1995-01-20	1995-03-08	Wellcome Found	Guanine derivative
ATE254463T1 (de) *	1996-01-19	2003-12-15	Glaxo Group Ltd	Verwendung von valaciclovir zur herstellung eines arzneimittels zur behandlung von genitalherpes durch einmal tägliche verabreichung
IT1283447B1 (it) *	1996-07-18	1998-04-21	Ind Chimica Srl	Processo di preparazione del valaciclovir e relativi intermedi
CA2278474A1 (en) *	1997-01-17	1998-07-23	Ajinomoto Co., Inc.	Novel z-valacyclovir crystals
GB0010446D0 (en) *	2000-04-28	2000-06-14	Glaxo Wellcome Kk	Pharmaceutical formulation
SI1757606T1 (sl) *	2001-02-24	2009-10-31	Boehringer Ingelheim Pharma	Ksantinski derivati za uporabo kot zdravila kot tudi postopek za njihovo pripravo
EP1436295A4 (en) *	2001-09-07	2007-07-11	Teva Pharma	CRISTALLINE FORMS OF VALACYCLOVIR HYDROCHLORIDE
EP1453834A1 (en) *	2001-11-05	2004-09-08	Glaxo Group Limited	Anhydrous crystal form of valaciclovir hydrochloride
HRP20040511A2 (en) *	2001-11-14	2004-10-31	Teva Pharma	Synthesis and purification of valacyclovir
EP1517678A2 (en) *	2002-06-24	2005-03-30	Ranbaxy Laboratories Limited	Process for the preparation of robust formulations of valacyclovir hydrochloride tablets
US7407955B2 (en)	2002-08-21	2008-08-05	Boehringer Ingelheim Pharma Gmbh & Co., Kg	8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US20050043329A1 (en) *	2002-09-06	2005-02-24	Shlomit Wizel	Crystalline forms of valacyclovir hydrochloride
CA2501557A1 (en) *	2002-10-16	2004-04-29	Teva Pharmaceutical Industries Ltd	Method for reducing residual alcohols in crystalline valacyclovir hydrochloride
US20050059684A1 (en) *	2002-10-16	2005-03-17	Ben-Zion Dolitzky	Method for reducing residual alcohols in crystalline valacyclovir hydrochloride
CA2548608A1 (en) *	2002-12-09	2004-06-24	Texcontor Etablissement	Anhydrous crystalline form of valacyclovir hydrochloride
AU2003232719A1 (en) *	2003-05-30	2005-01-21	Eos Eczacibasi Ozgun Kimyasal Urunler Sanayi Ve Ticaret A.S.	Novel crystalline forms of valacyclovir hydrochloride
TW200510414A (en) *	2003-06-02	2005-03-16	Teva Pharma	Novel crystalline forms of valacyclovir hydrochloride
CA2552560A1 (en) *	2004-01-21	2005-08-11	Teva Pharmaceutical Industries Ltd.	Process for the preparation of valacyclovir hydrochloride
US7501426B2 (en)	2004-02-18	2009-03-10	Boehringer Ingelheim International Gmbh	8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
WO2006011874A1 (en) *	2004-06-30	2006-02-02	Teva Pharmaceutical Industries, Ltd.	Method for reducing residual alcohols in crystalline valacyclovir hydrochloride
DE102004054054A1 (de) *	2004-11-05	2006-05-11	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
US20060178512A1 (en) *	2005-02-04	2006-08-10	Cheruthur Govindan	Method for preparing amino acid esters of nucleoside analogues
WO2006127217A2 (en) *	2005-05-25	2006-11-30	Eli Lilly And Company	Cyclopropanecarboxylate esters of acyclovir
EP1746098A1 (en) *	2005-07-21	2007-01-24	SOLMAG S.p.A.	Valacyclovir polymorphs and a process for the preparation thereof
DE102005035891A1 (de) *	2005-07-30	2007-02-08	Boehringer Ingelheim Pharma Gmbh & Co. Kg	8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
US20070112193A1 (en) *	2005-11-14	2007-05-17	Khunt Mayur D	Valacyclovir process
KR101452915B1 (ko)	2006-05-04	2014-10-21	베링거 인겔하임 인터내셔날 게엠베하	다형태
EP1852108A1 (en)	2006-05-04	2007-11-07	Boehringer Ingelheim Pharma GmbH & Co.KG	DPP IV inhibitor formulations
PE20080251A1 (es)	2006-05-04	2008-04-25	Boehringer Ingelheim Int	Usos de inhibidores de dpp iv
CN1903854B (zh) *	2006-08-09	2012-05-23	丽珠医药集团股份有限公司	一种合成盐酸伐昔洛韦的方法
US20080167325A1 (en) *	2006-12-27	2008-07-10	Bs Praveen Kumar	Valacyclovir compositions
US20080281099A1 (en) *	2007-05-07	2008-11-13	Mayur Devjibhai Khunt	Process for purifying valacyclovir hydrochloride and intermediates thereof
GB0710277D0 (en) *	2007-05-30	2007-07-11	Univ Birmingham	Use of antivirals in the treatment of medical disorders
NZ600126A (en) *	2007-08-17	2013-12-20	Boehringer Ingelheim Int	Purine derivatives for use in the treatment of fap-related diseases
WO2009031576A1 (ja) *	2007-09-03	2009-03-12	Ajinomoto Co., Inc.	バラシクロビル塩酸塩結晶の製造方法
US20090076039A1 (en) *	2007-09-14	2009-03-19	Protia, Llc	Deuterium-enriched valacyclovir
PE20140960A1 (es)	2008-04-03	2014-08-15	Boehringer Ingelheim Int	Formulaciones que comprenden un inhibidor de dpp4
PE20100156A1 (es) *	2008-06-03	2010-02-23	Boehringer Ingelheim Int	Tratamiento de nafld
KR20190016601A (ko)	2008-08-06	2019-02-18	베링거 인겔하임 인터내셔날 게엠베하	메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
UY32030A (es)	2008-08-06	2010-03-26	Boehringer Ingelheim Int	"tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
WO2010018217A2 (en) *	2008-08-15	2010-02-18	Boehringer Ingelheim International Gmbh	Organic compounds for wound healing
MX2011002558A (es)	2008-09-10	2011-04-26	Boehringer Ingelheim Int	Terapia de combinacion para el tratamiento de diabetes y estados relacionados.
US20200155558A1 (en)	2018-11-20	2020-05-21	Boehringer Ingelheim International Gmbh	Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
AU2009331471B2 (en)	2008-12-23	2015-09-03	Boehringer Ingelheim International Gmbh	Salt forms of organic compound
AR074990A1 (es)	2009-01-07	2011-03-02	Boehringer Ingelheim Int	Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
KR20120107080A (ko)	2009-11-27	2012-09-28	베링거 인겔하임 인터내셔날 게엠베하	리나글립틴과 같은 ｄｐｐ－ｉｖ 억제제를 사용한 유전자형 검사된 당뇨병 환자의 치료
KR101927068B1 (ko)	2010-05-05	2018-12-10	베링거 인겔하임 인터내셔날 게엠베하	체중 감소 치료에 후속하는 dpp-4 억제제에 의한 순차적 병용 요법
WO2011158252A1 (en)	2010-06-15	2011-12-22	Matrix Laboratories Ltd	Process for the preparation of valacyclovir hydrochloride polymorphic form ii
KR20220025926A (ko)	2010-06-24	2022-03-03	베링거 인겔하임 인터내셔날 게엠베하	당뇨병 요법
AR083878A1 (es)	2010-11-15	2013-03-27	Boehringer Ingelheim Int	Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
CN102584825B (zh) *	2011-01-17	2014-04-02	四川科伦药物研究有限公司	一种合成盐酸伐昔洛韦的方法
CN103781788B (zh)	2011-07-15	2016-08-17	勃林格殷格翰国际有限公司	经取代的喹唑啉、其制备及其在药物组合物中的用途
EP2852592A4 (en) *	2011-11-25	2015-12-23	Piramal Entpr Ltd	PROCESS FOR THE PREPARATION OF VALACYCLOVIR CHLORHYDRATE
US9555001B2 (en)	2012-03-07	2017-01-31	Boehringer Ingelheim International Gmbh	Pharmaceutical composition and uses thereof
WO2013171166A1 (en)	2012-05-14	2013-11-21	Boehringer Ingelheim International Gmbh	A xanthine derivative as dpp-4 inhibitor for use in the treatment of sirs and/or sepsis
JP6224084B2 (ja)	2012-05-14	2017-11-01	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	糸球体上皮細胞関連障害及び／又はネフローゼ症候群の治療に用いるｄｐｐ−４阻害薬としてのキサンチン誘導体
WO2013174767A1 (en)	2012-05-24	2013-11-28	Boehringer Ingelheim International Gmbh	A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
JP6615109B2 (ja)	2014-02-28	2019-12-04	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	Ｄｐｐ−４阻害薬の医学的使用
MX390363B (es)	2016-06-10	2025-03-20	Boehringer Ingelheim Int	Combinacion de linagliptina y metformina
CN110437231B (zh) *	2019-09-04	2022-04-29	上药康丽（常州）药业有限公司	一种盐酸伐昔洛韦无水晶型ⅰ的制备方法
WO2021209563A1 (en)	2020-04-16	2021-10-21	Som Innovation Biotech, S.A.	Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AP160A (en) *	1987-08-15	1991-11-18	The Wellcome Foundation Ltd	Therapeutic acyclic nucleosides.
US5831075A (en) *	1993-06-10	1998-11-03	Rolabo Sl	Amino acid ester of nucleoside analogues
GB9501178D0 (en) *	1995-01-20	1995-03-08	Wellcome Found	Guanine derivative

1995
- 1995-01-20 GB GBGB9501178.9A patent/GB9501178D0/en active Pending
1996
- 1996-01-19 EP EP96900631A patent/EP0804436B1/en not_active Expired - Lifetime
- 1996-01-19 IL IL11683196A patent/IL116831A/en not_active IP Right Cessation
- 1996-01-19 AP APAP/P/1997/001058A patent/AP662A/en active
- 1996-01-19 EA EA199700124A patent/EA000364B1/ru not_active IP Right Cessation
- 1996-01-19 PL PL96321326A patent/PL182175B1/pl not_active IP Right Cessation
- 1996-01-19 SI SI9630717T patent/SI0804436T1/sl unknown
- 1996-01-19 NZ NZ298851A patent/NZ298851A/xx not_active IP Right Cessation
- 1996-01-19 SK SK965-97A patent/SK285329B6/sk not_active IP Right Cessation
- 1996-01-19 RS YU3396A patent/RS49518B/sr unknown
- 1996-01-19 BR BR9606768A patent/BR9606768A/pt active IP Right Grant
- 1996-01-19 CA CA002210799A patent/CA2210799C/en not_active Expired - Fee Related
- 1996-01-19 GE GEAP19963845A patent/GEP20001940B/en unknown
- 1996-01-19 EE EE9700175A patent/EE03528B1/xx not_active IP Right Cessation
- 1996-01-19 CZ CZ0229497A patent/CZ297065B6/cs not_active IP Right Cessation
- 1996-01-19 AT AT96900631T patent/ATE302777T1/de not_active IP Right Cessation
- 1996-01-19 UA UA97084268A patent/UA46001C2/uk unknown
- 1996-01-19 AU AU44539/96A patent/AU702794B2/en not_active Ceased
- 1996-01-19 HR HR960024A patent/HRP960024B1/xx not_active IP Right Cessation
- 1996-01-19 AR ARP960101082A patent/AR002270A1/es not_active Application Discontinuation
- 1996-01-19 DE DE69635106T patent/DE69635106T2/de not_active Expired - Lifetime
- 1996-01-19 DK DK96900631T patent/DK0804436T3/da active
- 1996-01-19 HU HU9801836A patent/HU222993B1/hu not_active IP Right Cessation
- 1996-01-19 WO PCT/GB1996/000117 patent/WO1996022291A1/en not_active Ceased
- 1996-01-19 FI FI973063A patent/FI973063A7/fi not_active Application Discontinuation
- 1996-01-19 JP JP52213196A patent/JP3176633B2/ja not_active Expired - Fee Related
- 1996-01-19 ZA ZA96449A patent/ZA96449B/xx unknown
- 1996-01-19 US US08/875,173 patent/US6107302A/en not_active Expired - Lifetime
- 1996-01-19 TR TR97/00656T patent/TR199700656T1/xx unknown
- 1996-01-19 RO RO97-01334A patent/RO118693B1/ro unknown
- 1996-01-19 ES ES96900631T patent/ES2248806T3/es not_active Expired - Lifetime
- 1996-01-19 KR KR1019970704916A patent/KR100376074B1/ko not_active Expired - Lifetime
- 1996-01-19 CN CN96192662A patent/CN1049893C/zh not_active Expired - Fee Related
- 1996-01-19 IN IN102MA1996 patent/IN182468B/en unknown
1997
- 1997-07-15 IS IS4527A patent/IS2268B/is unknown
- 1997-07-16 OA OA70051A patent/OA10499A/en unknown
- 1997-07-18 NO NO19973326A patent/NO315558B1/no not_active IP Right Cessation
- 1997-08-14 BG BG101833A patent/BG63393B1/bg unknown
1999
- 1999-10-29 UY UY25779A patent/UY25779A1/es not_active IP Right Cessation
2005
- 2005-11-16 CY CY0500061A patent/CY2531B1/xx unknown

Also Published As

Publication number	Publication date
IS2268B (is)	2007-07-15
SK96597A3 (en)	1998-02-04
CZ297065B6 (cs)	2006-08-16
EP0804436B1 (en)	2005-08-24
HUP9801836A3 (en)	1999-06-28
CZ229497A3 (en)	1997-12-17
NO315558B1 (no)	2003-09-22
BR9606768A (pt)	1997-12-30
CY2531B1 (en)	2006-04-12
AU702794B2 (en)	1999-03-04
HU222993B1 (hu)	2004-01-28
HUP9801836A2 (hu)	1999-05-28
EE03528B1 (et)	2001-10-15
DK0804436T3 (da)	2005-12-27
TR199700656T1 (xx)	1998-03-21
CN1179159A (zh)	1998-04-15
IN182468B (xx)	1999-04-17
AR002270A1 (es)	1998-03-11
NZ298851A (en)	1999-01-28
ATE302777T1 (de)	2005-09-15
ZA96449B (en)	1996-08-07
PL182175B1 (pl)	2001-11-30
UY25779A1 (es)	2000-08-21
IL116831A (en)	1998-10-30
IL116831A0 (en)	1996-05-14
NO973326L (no)	1997-09-16
CA2210799A1 (en)	1996-07-25
KR19980701525A (ko)	1998-05-15
WO1996022291A1 (en)	1996-07-25
CA2210799C (en)	2008-06-10
HRP960024B1 (en)	2005-08-31
EA199700124A1 (ru)	1997-12-30
PL321326A1 (en)	1997-12-08
EE9700175A (et)	1998-02-16
IS4527A (is)	1997-07-15
HRP960024A2 (en)	1997-10-31
AP662A (en)	1998-08-19
DE69635106T2 (de)	2006-06-08
KR100376074B1 (ko)	2003-06-02
BG63393B1 (bg)	2001-12-29
CN1049893C (zh)	2000-03-01
GB9501178D0 (en)	1995-03-08
MX9705462A (es)	1997-10-31
OA10499A (en)	2002-04-10
EA000364B1 (ru)	1999-06-24
BG101833A (bg)	1998-04-30
SI0804436T1 (sl)	2006-02-28
RS49518B (sr)	2006-10-27
EP0804436A1 (en)	1997-11-05
FI973063A0 (fi)	1997-07-18
FI973063A7 (fi)	1997-09-18
JPH11503718A (ja)	1999-03-30
RO118693B1 (ro)	2003-09-30
AP9701058A0 (en)	1997-10-31
US6107302A (en)	2000-08-22
ES2248806T3 (es)	2006-03-16
UA46001C2 (uk)	2002-05-15
AU4453996A (en)	1996-08-07
JP3176633B2 (ja)	2001-06-18
SK285329B6 (sk)	2006-11-03
DE69635106D1 (de)	2005-09-29
YU3396A (sh)	1998-12-23
NO973326D0 (no)	1997-07-18
GEP20001940B (en)	2000-02-05

Publication	Publication Date	Title
ATE302777T1 (de)	2005-09-15	Guaninderivat
DE69522717D1 (de)	2001-10-18	Chinazolinderivate
DE69611361D1 (de)	2001-02-01	Chinazolin-derivate
NO974103L (no)	1997-11-05	Arylsulfonylaminohydroksamsyre-derivater
DE69610698D1 (de)	2000-11-23	Chinazolin-derivate
PT833828E (pt)	2003-02-28	Derivados de rapamicina
BR9611834A (pt)	1999-03-09	Derivados de oximetóxi-3-aril-pirona
ATE199150T1 (de)	2001-02-15	Diphenylmethylenpiperidin-derivate
NO964667D0 (no)	1996-11-05	Purin-6-on-derivater
DE69601527D1 (de)	1999-03-25	Pyrrolylbenzimidazol-Derivate
ATA100695A (de)	1998-03-15	Prothrombin-derivate
ATE240307T1 (de)	2003-05-15	Diarylalkenylamin-derivate
DE69627830D1 (de)	2003-06-05	Pyrazol-derivate
DE59607054D1 (de)	2001-07-19	4-Amino-benzoylguanidin-Derivate
ATE177102T1 (de)	1999-03-15	Chromanderivate
DE59610106D1 (de)	2003-03-13	Fluorbenzylether-Derivate
DE69624122D1 (de)	2002-11-07	Aza-anthracyclinone-derivate
BR9603508A (pt)	1998-05-12	Derivados de alquenil-benzoilguanidina
ATE202088T1 (de)	2001-06-15	4-mercapto-benzoylguanidin-derivate
DE69620514D1 (de)	2002-05-16	5-aminoflavon-derivate
ATA45796A (de)	1999-09-15	Lysin-prolin-derivate
DE59600405D1 (de)	1998-09-10	Gehhilfe
DK0705833T3 (da)	2004-11-15	DC-89-derivat
FI950104A0 (fi)	1995-01-10	Isolerad yttervaegg till timmerhus
BR9603733A (pt)	1998-05-26	Derivados de cloropiridilcarbonila

Legal Events

Date	Code	Title	Description
2010-08-03	FD	Application lapsed